Shanghai Kedu Medical Technology

The core of Kedu's business is a service model focused on the holistic management of a hospital's entire inventory of medical equipment. The company's revenue stream is derived from providing these extensive management services, which are designed to enhance equipment efficiency and uptime. This approach shifts the commercial incentive from a traditional break-fix model, where revenue is tied to the frequency of repairs, to one where profitability is aligned with the operational reliability of the equipment. Kedu serves a substantial client base, managing assets for hundreds of hospitals across China.

A key component of their offering is the proprietary "Archimedes Platform," a digital management system for medical assets. This software enables the digitization of equipment management, creating traceable, paperless workflows. The platform provides hospital administrators with data-driven insights for decision-making regarding equipment procurement and maintenance strategies. Further technological integration includes the use of IoT to monitor equipment status in real-time and AI-powered solutions like the "AI pupil shadow glasses" and a "digital cockpit" for executives to get a high-level overview of all hospital equipment assets. In March 2025, the company showcased solutions for dynamic monitoring of large equipment and intelligent management of operating room devices, signaling a focus on AI and IoT applications to further enhance their service offerings.

The company has secured significant financial backing to fuel its expansion. A notable milestone was the completion of a Series C funding round of nearly USD 60 million in December 2019, led by China Merchants Capital with participation from investors including UOB Venture Management and Infinity Group. This capital was earmarked for national business expansion. According to public records, the company's legal representative is Ni Jun and its CEO is Qi Menghui.